Clinical trial
Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance
NCT00447811 · Bausch Health Americas, Inc., Industry · Completed
Key facts
| NCT number | NCT00447811 |
|---|---|
| Title | Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance |
| Official title | Two Ascending Single Doses Crossover, Placebo Controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MOA-728 Administered Orally to Subjects on Stable Methadone Maintenance |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Methadone-maintenance Subjects |
| Intervention type | Drug |
| Interventions | MOA-728 |
| Start date | Mar 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Mar 15, 2007 |
| Last update posted | Nov 25, 2019 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: